| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,206 |
7,421 |
$286K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
426 |
418 |
$47K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
673 |
601 |
$37K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
340 |
326 |
$36K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
246 |
243 |
$28K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
365 |
357 |
$6K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,864 |
1,863 |
$4K |
| 90686 |
|
629 |
620 |
$3K |
| 90700 |
|
206 |
206 |
$2K |
| 92551 |
|
1,626 |
1,580 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13 |
13 |
$2K |
| 90713 |
|
100 |
100 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
50 |
49 |
$1K |
| 90670 |
|
155 |
153 |
$950.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
173 |
161 |
$846.10 |
| 90648 |
|
75 |
75 |
$803.00 |
| 99050 |
|
12 |
12 |
$701.24 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
194 |
193 |
$661.87 |
| 0071A |
|
15 |
15 |
$400.00 |
| 99173 |
|
2,346 |
2,309 |
$367.06 |
| 96127 |
|
526 |
511 |
$335.11 |
| 90680 |
|
40 |
40 |
$280.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$231.37 |
| 90633 |
|
12 |
12 |
$120.00 |
| 90461 |
|
241 |
225 |
$119.72 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$117.84 |
| 90707 |
|
51 |
50 |
$110.00 |
| 92552 |
|
790 |
776 |
$72.00 |
| 83655 |
|
398 |
395 |
$39.11 |
| 85018 |
|
13 |
12 |
$2.26 |
| 96160 |
|
488 |
485 |
$0.00 |
| 99072 |
|
2,336 |
2,160 |
$0.00 |
| 90715 |
|
13 |
13 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
291 |
280 |
$0.00 |
| 87428 |
|
76 |
69 |
$0.00 |
| 90698 |
|
13 |
13 |
$0.00 |
| 90716 |
|
40 |
39 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
64 |
55 |
$0.00 |
| 90620 |
|
72 |
71 |
$0.00 |
| 90619 |
|
91 |
91 |
$0.00 |
| 90651 |
|
82 |
81 |
$0.00 |
| 90656 |
|
122 |
122 |
$0.00 |
| 90677 |
|
13 |
12 |
$0.00 |